-
Exome-wide somatic mutation characterization of small bowel adenocarcinoma
Study
EGAS00001002559
-
Exome sequencing data from two myelosarcomas
Study
EGAS00001002562
-
Pilot study for Illumina TST170 NGS panel on cutaneous T cell lymphoma samples
Study
EGAS00001002567
-
The genomic landscape of cutaneous squamous cell carcinoma from immunosuppressed and immunocompetent patients reveals common drivers and a novel mutational signature associated with chronic azathioprine exposure
Study
EGAS00001002612
-
Whole-exome sequencing of ovarian clear cell carcinoma in clinical outliers
Study
EGAS00001004248
-
We performed whole-exome sequencing of 20 samples (10 actinic keratosis and 10 cutaneous squamous cell carcinoma) to investigate a potential relationship between DNA methylation-based subtypes and genetic mutation patterns (Rodriguez-Paredes et al., Nat Commun 2017)
Study
EGAS00001002670
-
Alternative splicing isoforms in patient-derived hepatocellular carcinoma cells
Study
EGAS00001002697
-
Gut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
Study
EGAS00001002698
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
Study
EGAS00001002707
-
Aggressive genomic features in clinicallyindolent primary HHV8-negative effusion-based lymphoma
Study
EGAS00001002743
-
Defective T-cell expansion in RASGRP1 deficiency
Study
EGAS00001002753
-
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
Study
EGAS00001002757
-
Colorectal adenomas and carcinomas NKI-AvL TGO series Gut2009
Study
EGAS00001002758
-
Mutational spectrum of highly differentiated, fusion-negative rhabdomyosarcoma (set 2).
Study
EGAS00001002771
-
An integrated molecular study of 20 hepatoblastoma pairs using whole genome sequencing and RNA sequencing
Study
EGAS00001002772
-
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Study
EGAS00001002786
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Somatic IL4R Hotspot Mutations in Primary Mediastinal Large B-cell lymphoma lead to constitutive JAK-STAT activation
Study
EGAS00001002796
-
Molecular subtypes of malignant peritoneal mesothelioma
Study
EGAS00001002820
-
Whole exome sequencing of longitudinal samples from a melanoma patient receiving MEK plus CDK4/6 inhibitor therapy.
Study
EGAS00001002846
-
Whole-genome and transcriptome sequencing of tumor-stage mycosis fungoides
Study
EGAS00001002860
-
Targeted exome sequencing of pleomorphic invasive lobular carcinoma (PILC).
Study
EGAS00001002871
-
Foundation Medicine Genomic Data Used to Identify Prognostic Markers and Fusion Genes in Multiple Myeloma
Study
EGAS00001002874
-
Genomic Heterogeneity and the Small Renal Mass
Study
EGAS00001002919
-
SS18-SSX-mediated hijacking of BAF complexes drives synovial sarcoma
Study
EGAS00001002920
-
Colorectal advanced adenomas NKI-AvL TGO COCOS series
Study
EGAS00001002952
-
Colorectal adenomas, NKI-AvL TGO series Stool-Proteomics
Study
EGAS00001002953
-
Single cell exome sequencing of lung adenocarcinoma
Study
EGAS00001002972
-
RNAseq of Follicular Lymphoma
Study
EGAS00001002980
-
Host whole genome variations are associated with neurocognitive outcome in survivors of pediatric medulloblastoma
Study
EGAS00001002996
-
Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Study
EGAS00001002998
-
Genomic profiling of paediatric glioma cell lines
Study
EGAS00001003006
-
Biallelic tumor suppressor loss and DNA repair defects in de novo small cell prostate cancer
Study
EGAS00001003007
-
The evolutionary history of human colitis-associated colorectal cancer
Study
EGAS00001003028
-
Identification of recurrent mutations in Cushing’s disease
Study
EGAS00001003029
-
Patient-derived neuroblastoma model system OHC-NB1
Study
EGAS00001003031
-
Capture Hi-C on Hodgkin lymphoma cell line L-428
Study
EGAS00001003032
-
ChIP-seq data of Hodgkin lymphoma cell line L-428
Study
EGAS00001003033
-
AUBTRG - Whole Exome Sequencing of Diffuse Glioma Samples
Study
EGAS00001003035
-
Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations
Study
EGAS00001003040
-
Evolutionary dynamics of residual disease in human glioblastoma
Study
EGAS00001003043
-
Ewings Sarcoma RNA-Seq
Study
EGAS00001003062
-
CCND1-negative MCL
Study
EGAS00001003060
-
Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes
Study
EGAS00001003093
-
Feasibility Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN) in resectable stage III melanoma patients
Study
EGAS00001003099
-
Primary plasma cell leukemia (pPCL) samples were sequenced using the Nimblegen MedExome hybridization capture to detect translocations, copy number changes, and mutations in 20 pPCL samples and patient matched controls.
Study
EGAS00001003104
-
Whole-exome sequencing of extranodal NK/T cell lymphoma
Study
EGAS00001004357
-
Whole exome sequencing of small cell neuroendocrine cancer of the cervix
Study
EGAS00001003142
-
Single cell sequencing of endoscopic biopsies from Barrett's oesophagus and proximal tissue from the normal GI tract
Study
EGAS00001003144
-
DNA Methylation-based diagnostic biomarkers for ESCC in Han Chinese population
Study
EGAS00001003158
-
Tumor-associated preferred end coordinates and somatic variants as signatures of circulating tumor DNA
Study
EGAS00001003160
-
Study the differences at the trascriptome level between iNKT and T cells
Study
EGAS00001003176
-
The molecular landscape of glioma in patients with Neurofibromatosis 1.
Study
EGAS00001003186
-
Hyperhaploid Multiple Myeloma
Study
EGAS00001003203
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Characterizing the immune and genome landscapes for osteosarcoma
Study
EGAS00001003247
-
Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
Study
EGAS00001003255
-
Whole Tumor spatial heterogeneity in metastatic melanoma
Study
EGAS00001003292
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Study
EGAS00001003306
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer RNA-Seq
Study
EGAS00001003307
-
MGA-NUTM1 fusion in high grade spindle cell sarcoma
Study
EGAS00001003341
-
Exome sequencing of a novel cervical cancer cell line
Study
EGAS00001003343
-
CAF-S3 subset in human breast and ovarian cancers
Study
EGAS00001003344
-
Glioma Genomics Committee
Dac
EGAC00001000153
-
Single-cell RNA-seq of immune cells sorted from human melanoma tumors
Study
EGAS00001003363
-
Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma
Study
EGAS00001003370
-
Whole genome sequencing of Ewings Sarcoma
Study
EGAS00001003385
-
Hepatocellular carcinoma xenografts established from needle biopsies preserve the characteristics of the originating tumors
Study
EGAS00001003396
-
Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform
Study
EGAS00001003846
-
Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases
Study
EGAS00001003408
-
DAC for seminoma genomic data
Dac
EGAC00001000231
-
Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma
Study
EGAS00001003438
-
Multi-region exome sequencing of lung adenocarcinoma precursors -1
Study
EGAS00001003439
-
Carcinosarcoma Data Access Committee
Dac
EGAC00001000234
-
Clonal architectures predict clinical outcome in clear cell renal cell carcinoma
Study
EGAS00001003447
-
Adenoma to Carcinoma transition in Colorectal Cancer
Study
EGAS00001003468
-
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma (H033)
Study
EGAS00001003481
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001003488
-
Predicting brain tumor recurrence: development and validation of a DNA-methylation based nomogram in meningioma
Study
EGAS00001003490
-
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
Study
EGAS00001003493
-
Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases
Study
EGAS00001003497
-
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients
Study
EGAS00001003539
-
Whole Genome Sequencing Reveals Potential Therapeutic Strategy for Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
Study
EGAS00001003876
-
Evolution of GBM through therapy
Study
EGAS00001003546
-
Genetic modification of primary human B cells to model high-grade lymphoma
Study
EGAS00001003560
-
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
Study
EGAS00001003564
-
RNA-sequencing of adult T-cell leukemia/lymphoma samples
Study
EGAS00001003575
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Analysis of four key cell types (epithelial, fbroblast, myeloid and T cells)
Study
EGAS00001003579
-
Single cell transcriptomic and genomic profiling of carcinogenesis in patients with familial adenomatous polyposis
Study
EGAS00001003598
-
A Phase II Trial of High Dose Interleukin-2 and Multi-site Stereotactic Ablative Radiotherapy for Patients with Metastatic Renal Cell Carcinoma
Study
EGAS00001003605
-
Recapitulation of genetic predisposition to medulloblastoma in human neuroepithelial stem cells
Study
EGAS00001003620
-
WGS of Roma (Romani/Rroma) and European/Romanian individuals from Romania
Study
EGAS00001003624
-
UAMS Smoldering Myeloma Myeloma Sequencing
Study
EGAS00001003629
-
UAMS Smoldering Myeloma Timeline Cohort
Study
EGAS00001003687
-
Analysis of copy number variation landscape of glioma by shallow coverage whole genome sequencing
Study
EGAS00001003690
-
Detecting and tracking circulating tumour DNA copy number profiles during first line chemotherapy in oesophagogastric adenocarcinoma
Study
EGAS00001003695
-
Analysis of the genomic landscape of chemoresistant multiple myeloma
Study
EGAS00001003709
-
ID1 in glioblastoma
Study
EGAS00001003711